Cite
HARVARD Citation
Papi, A. et al. (2018). Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet. 391 (10125), pp. 1076-1084. [Online].